by Neoteryx, on October 20,2020
October 2020 — Alcohol-related death statistics around the world are staggering. Numbers from the World Health Organization (WHO) reveal that each year, approximately three million people around the globe die …
Read Storyby Neoteryx, on October 2,2019
AUSTIN, TX – GX Sciences™ is now offering quick and easy blood analysis testing, known as Microsampling, through a unique Mitra® device, by Neoteryx. Blood Microsampling is an efficient and more simplified method of traditional …
Read Storyby Neoteryx, on November 12,2018
At-home blood sampling streamlines the process of therapeutic drug monitoring and creates comfort and emotional safety for children UNITED KINGDOM and TORRANCE, CA (November 07, 2018) – Neoteryx LLC, inventor of Volumetric …
Read Storyby Neoteryx, on July 18,2018
Dried blood samples replace urine monitoring for patients of alcohol and opioid addiction. TORRANCE, California – Today, Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, …
Read Storyby Emerson Dameron, on December 15,2017
Recently, Volumetric Absorptive Microsampling (VAMS™) technology helped a group of organ transplant patients summit Mt. Kilimanjaro. Now students and scientists from the biomedical engineering program at Duke University have found another transformative …
Read StoryThe latest product releases, company news and microsampling industry updates from Neoteryx.
If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
Fact Sheet & FAQs
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.